Pharmaids Pharmaceuticals Limited reported earnings results for the full year ended March 31, 2024. For the full year, the company reported sales was INR 151.12 million. Revenue was INR 159.9 million.

Net loss was INR 79.68 million compared to INR 75.56 million a year ago. Basic loss per share from continuing operations was INR 3.56 compared to INR 5.83 a year ago. Diluted loss per share from continuing operations was INR 3.56 compared to INR 5.83 a year ago.